| Dr Ron Burg, PHD | |
|
900 Welch Rd, Suite 400, Palo Alto, CA 94304-1805 | |
| (650) 303-5882 | |
| Not Available |
| Full Name | Dr Ron Burg |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 900 Welch Rd, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518172485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY17175 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ron Burg, PHD 900 Welch Rd, Suite 400, Palo Alto, CA 94304-1805 Ph: (650) 303-5882 | Dr Ron Burg, PHD 900 Welch Rd, Suite 400, Palo Alto, CA 94304-1805 Ph: (650) 303-5882 |
News Archive
MO BIO Laboratories, Inc., the leader in soil, water and microbial nucleic acid purification, announces the launch of an innovative new product, the PowerWater Sterivex DNA Isolation Kit.
A Clinical Perspectives article published in the November 2014 issue of the Journal of the American Academy of Child and Adolescent Psychiatry proposes a tool to empower stakeholders, guide caregivers, and provide a rationale for advocates, when considering the systems of support offered to people with an autism spectrum disorder (ASD).
Chair Max Baucus (D-Mont.) on Tuesday after a meeting of committee leaders said that the White House opposes the use of a decrease in Medicare Advantage indirect medical education funds to offset the cost of a provision in a broader Medicare bill that would delay for 18 months a scheduled 10.6% reduction in physician reimbursements, CQ HealthBeat reports.
IBS scientists at the Center for Self-Assembly and Complexity, within the Institute for Basic Science, invented a hydrogel to fight rheumatoid arthritis and other diseases. Published in Advanced Materials, this jelly-like material could be used to absorb extra fluids in swelling joints and release drugs.
Lexicon Pharmaceuticals, Inc., announced today that LX4211, an investigational, oral, dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2), showed substantial, dose-dependent, statistically-significant reductions in hemoglobin A1c (HbA1c) in a Phase 2b trial in patients diagnosed with poorly-controlled type 2 diabetes who were concurrently treated with metformin, an established diabetes therapy.
› Verified 5 days ago
Dr. Zoi Dorit Eliou, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 665 Lytton Ave # 4, Palo Alto, CA 94301 Phone: 650-704-9424 | |
Dr. Zahra Murtaza, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 650-617-3829 | |
Diana Naranjo, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 401 Quarry Rd, Child And Adolescent Psychiatry, Palo Alto, CA 94304 Phone: 650-723-5511 Fax: 650-724-7389 | |
Susan Spinrad, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 560 Oxford Ave, Suite 3b, Palo Alto, CA 94306 Phone: 650-599-5825 | |
Dr. Lital Koropitzer, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 825 El Camino Real, Palo Alto, CA 94301 Phone: 650-223-6400 | |
Barbara M Sourkes, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Dr. Ferol F. Larsen, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 555 Middlefield Rd, Palo Alto, CA 94301 Phone: 650-326-6896 Fax: 650-326-6896 |